Home › Melanoma › Arizona › Scottsdale
Pag-aaral pangklinika para sa Melanoma sa Scottsdale, AZ
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Scottsdale. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Nagre-recruitPhase 1/2
- HonorHealth Research Institute, Scottsdale
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Nagre-recruitPhase 1/2
- Arizona State University-Honor Health Research Institute, Scottsdale
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- HonorHealth Research Institute, Scottsdale
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Nagre-recruitPhase 3
- Mayo Clinic Scottsdale - PPDS, Scottsdale
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- HonorHealth Research Insisute, Scottsdale
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Nagre-recruitPhase 1/2
- HonorHealth Research and Innovation Institute, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Nagre-recruitPhase 1/2
- Mayo Clinic in Arizona, Scottsdale
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Nagre-recruitPhase 1/2
- HonorHealth Research Institute, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1
- HonorHealth Research Institute, Scottsdale
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN33 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA26 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Columbus, OH21 pag-aaral
- St. Louis, MO21 pag-aaral
- Atlanta, GA21 pag-aaral
- Durham, NC21 pag-aaral
Iba pang pag-aaral sa Scottsdale
- Kanser sa Suso18 pag-aaral
- Kanser (lahat ng uri)18 pag-aaral
- Metastatic Cancer17 pag-aaral
- Kanser sa Prostate17 pag-aaral
- Colorectal Cancer16 pag-aaral
- Non-Small Cell Lung Cancer15 pag-aaral
- Kanser sa Pancreas13 pag-aaral
- Ulcerative Colitis8 pag-aaral
- Kanser sa Baga8 pag-aaral
- Kanser sa Atay (Hepatocellular Carcinoma)7 pag-aaral
- Sakit ni Alzheimer7 pag-aaral
- Triple-Negative Breast Cancer7 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.